Placebo (Cohort 3)

BIOLOGICAL2 trials

Sponsors

Pfizer, AstraZeneca

Conditions

COVID-19, SARS-CoV-2Obesity

Phase 1

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

CompletedNCT05932641

AstraZenecaCOVID-19, SARS-CoV-2

Start: 2023-07-31End: 2024-12-05Updated: 2024-12-27

Phase 2

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

CompletedNCT04707313

Start: 2021-01-29End: 2023-10-11Updated: 2024-11-05

Related Papers

Efficacy and safety of danuglipron ( <scp>PF</scp> ‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study

Diabetes Obesity and Metabolism2025-06-208 citations